Jones Financial Companies’s ImmunityBio IBRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$370K Buy
50,171
+43,289
+629% +$296K ﹤0.01% 2178
2025
Q4
$13.6K Buy
6,882
+4,460
+184% +$10.1K ﹤0.01% 3094
2025
Q3
$6.15K Buy
2,422
+1,122
+86% +$2.89K ﹤0.01% 3286
2025
Q2
$3.51K Sell
1,300
-17,086
-93% -$45.9K ﹤0.01% 3263
2025
Q1
$57.7K Buy
18,386
+12,966
+239% +$39.3K ﹤0.01% 1998
2024
Q4
$13.9K Buy
5,420
+2,000
+58% +$8.33K ﹤0.01% 2395
2024
Q3
$13.4K Buy
3,420
+300
+10% +$1.39K ﹤0.01% 2105
2024
Q2
$19.7K Buy
3,120
+120
+4% +$791 ﹤0.01% 1540
2024
Q1
$16.1K Buy
+3,000
New +$13.6K ﹤0.01% 949

Other funds holding IBRX